A Clinical Study of 115 Patients with Extranodal Natural Killer/T-cell Lymphoma, Nasal Type

Clinical Oncology

Volumn 20, Issue 8, 2008, Pages 619-625

  Wu, X ^a   Li, P ^a   Zhao, J ^a   Yang, X ^a   Wang, F ^a   Yang, Y Q ^a   Fang, F ^a   Xu, Y ^a   Zhang, H ^a   Wang, W Y ^a   Yi, C ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Extranodal NK T cell lymphoma; nasal type; prognosis factors; treatment

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FOLINATE CALCIUM; INTERFERON; METHOTREXATE; PREDNISOLONE; VINCRISTINE;

ADULT; ARTICLE; CANCER CONTROL; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERNATIONAL PROGNOSTIC SCORING SYSTEM; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIPLE CYCLE TREATMENT; NATURAL KILLER T CELL; NOSE CANCER; PRIORITY JOURNAL; PROGNOSIS; RECURRENT CANCER; SEX DIFFERENCE; SURVIVAL RATE; SURVIVAL TIME; T CELL LYMPHOMA; TREATMENT OUTCOME;

ADULT; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHOMA, EXTRANODAL NK-T-CELL; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NOSE NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 51249101520     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2008.05.011     Document Type: Article

References (17)

1. Li Y.X., Coucke P.A., Li J.Y., et al. Primary non-Hodgkin's lymphoma of the nasal cavity: prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy. Cancer 83 (1998) 449-456
2. Wan M., Chow J., Lei K., et al. Allelotyping of gastrointestinal nasal-type NK/T-cell lymphoma. Leuk Res 28 (2004) 339-343
3. Al-Hakeem D.A., Fedele S., Carlos R., et al. Extranodal NK/T-cell lymphoma, nasal type. Oral Oncol 10 (2006) 10-16
4. John K., and Chan C. The new World Health Organization classification of the lymphomas: the past, the present and the future. Hematol Oncol 19 (2001) 129-150
5. He C., Dai X.S., Li Q.S., et al. Diagnosis of nasal T/NK-cell lymphoma. Chin J Clin Oncol Rehab 11 1 (2004) 40-42
6. Lien H.C., Lin C.W., Huang P.H., et al. Expression of cyclin-dependent kinase 6(cdk6) and frequent loss of CD44 in nasal-nasopharyngeal NK/T-cell lymphomas. Comparison with CD56-negative peripheral T-cell lymphomas. Lab Invest 80 (2000) 893-900
7. Kawa K., Okamura T., Yasui M., Sato E., and Inoue M. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease. Crit Rev Oncol Hematol 44 (2002) 251-257
8. Kim G.E., Yang W.I., Lee S., et al. The significance of B expression in patients with angiocentric lymphoma of the head and neck. Cancer 91 (2001) 23-43
9. Sakata K., Fuwa N., Kodaira T., et al. Analyses of dose-response in radiotherapy for patients with mature T/NK-cell lymphomas according to the WHO classification. Radiother Oncol 79 (2006) 179-184
10. Kim K., Chie E.K., Kim C.W., et al. Treatment outcome of angiocentric T-cell and NK/T-cell lymphoma, nasal type: radiotherapy versus chemoradiotherapy. Jpn J Clin Oncol 35 (2005) 1-5
11. Hu W.H., Chen M., Luo F.T., et al. Multivariate analysis of prognosis of patients with stage IE non-Hodgkin's lymphomas of the nasal cavity. Chin J Oncol 23 (2001) 240-243
12. Logsdon M.D., Ha C.S., Kavadi V.S., et al. Lymphoma of the nasal cavity and paranasal sinuses: improved outcome and altered prognostic factors with combined modality therapy. Cancer 80 (1997) 477-488
13. Li C.C., Tien H.F., Tang J.L., et al. Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer/T-cell or T-cell lymphoma. Cancer 100 2 (2004) 366-375
14. Liang R., Chen F., Lee C.Y., et al. Autologous bone marrow transplantation for primary nasal T/NK cell lymphoma. Bone Marrow Transplant 19 (1997) 91-93
15. Yong W., Zheng W., and Zhang Y. Clinical characteristics and treatment of midline nasal and nasal type NK/T cell lymphoma. Zhonghua Yi Xue Za Zhi 81 (2001) 773-775
16. Wilder R.B., Rodriguez M.A., Ha C.S., et al. Bulky disease in an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine and prednisone with or without radiotherapy for aggressive lymphoma. Cancer 91 (2001) 244-246
17. Mok T.S., Steinberg J., Chan A.T., et al. Application of the International Prognostic Index in a study of Chinese patients with non-Hodgkin's lymphoma and a high incidence of primary extranodal lymphoma. Cancer 82 (1998) 2439-2448